Changes in FeNO Value During Pulmonary Rehabilitation in Patients with Asthma (Asthma FeNO)

Schön Klinik Berchtesgadener Land

Status: Completed

Conditions: Asthmatics; Asthmatic Patients; Asthma Bronchiale

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT06751550

168/20

Details and patient eligibility

About

This study investigates the use of fractional exhaled nitric oxide (FeNO) measurement to monitor non-pharmacological therapy during a three-week inpatient rehabilitation programme for asthma patients. It compares FeNO levels (measured three times a day) with clinical parameters and quality of life to analyse daily fluctuations and the acute effect of exercise training on FeNO levels. As FeNO is a non-invasive biomarker of airway inflammation, this study aims to expand its role in therapy monitoring and explore its application in a rehabilitation setting.

Enrollment: 62 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• confirmed diagnosis of bronchial asthma (all disease severities)
• Chronic Obstructive Pulmonary Disease (COPD) with an asthma component, where the asthma component plays a clinically relevant role
• written informed consent

Exclusion criteria

• Chronic Obstructive Pulmonary Disease (COPD) as the primary disease
• unability to perform FeNO measurement independently

Trial design

62 participants in 1 patient group

Asthmatic patients